Evidence map›Paper›PMID 40511472›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Epidemiological changes in

Florian Tagini, Søren Anker Uldum, Carla Berengua, Branislav Ivan, Riccarda Capaul, Sophie Edouard, Adrien Fischer, Jacky Flipse, Diego García Martínez de Artola, Daniel Goldenberger and 21 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Spread ofEmerging microbes & infections · 2026
    Article
  2. Risk factors for severeFrontiers in pediatrics · 2026
    Article
  3. Article
  4. Surge inEmerging microbes & infections · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Florian TaginiInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Søren Anker UldumDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Carla BerenguaMicrobiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Branislav IvanUniversity Hospital Basel, Basel, Switzerland.
Riccarda CapaulZentrallabor, Kantonspital Graubünden, Chur, Switzerland.
Sophie EdouardIHU-Méditerranée Infection, Marseille, France.
Adrien FischerBacteriology Laboratory, Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland.
Jacky FlipseLaboratory for Medical Microbiology and Immunology, Rijnstate Hospital, Arnhem, the Netherlands.
Diego García Martínez de ArtolaHospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Daniel GoldenbergerUniversity Hospital Basel, Basel, Switzerland.
Edou HeddemaZuyderland Medical Centre, Glims, Sittard-Geleen, the Netherlands.
Mirjam HermansJeroen Bosch Hospital, s-Hertogenbosch, the Netherlands.
Frank ImkampUniversity of Zurich, Institute of Medical Microbiology, Zürich, Switzerland.
Darja KešeLaboratory for diagnostics of atypical bacterial infections, Institute of Microbiology and Immunology, Faculty of Medicine, Ljubljana, Slovenia.
Clara LejarragaMicrobiology laboratory, HUC, Bilbao, Spain.
Reto LienhardADMED Microbiologie, La Chaux-de-Fonds, Switzerland.
Carola MaffioliMCL Laboratories, Niederwangen, Switzerland.
Veerle MatheeussenUniversity Hospital Antwerp, Antwerp, Belgium.
Patrick M Meyer SauteurInfectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich, Switzerland.
Irena MitrovicLuzerner Kantonsspital, Lucerne, Switzerland.
Onya OpotaInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Christina OraschMEDISYN SA, Lucerne, Switzerland.
Pavel DrevinekMotol University Hospital, Prague, Czechia.
Olivia PeuchantDepartment of Bacteriology, Bordeaux University Hospital, Bordeaux, France.
Liu Po-YuTaichung Veterans General Hospital, Taichung, Taiwan.
Mirja PuolakkainenUniversity of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Melissa RemyMEDISYN SA, Lucerne, Switzerland.
Khoa Td ThaiStar-shl, Rotterdam, the Netherlands.
Nadia WohlwendLaboratory Dr. Risch, Buchs, Switzerland.
Gilbert GreubInstitute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
ESCMID Study Group for Mycoplasma and Chlamydia infections (ESGMAC)https://www.escmid.org/esgmac/.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundDuring the COVID-19 pandemic, non-pharmaceutical interventions (NPIs) such as social distancing, lockdowns and enhanced hygiene led to a decrease in respiratory pathogens. However, as NPIs were relaxed, a resurgence in several respiratory pathogens was observed including one local

Indexed as

Chlamydophila InfectionsChlamydophila pneumoniaeCOVID-19EuropeHumansPandemicsPolymerase Chain ReactionSARS-CoV-2Taiwanasthmabronchitismolecular diagnosisoutbreakPCRpneumoniaupsurge

Identifiers

PMID40511472
PMCPMC12164279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.